Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Actinogen Medical, Anpac Bio-Medical Science, Astellas, Astrazeneca, Celltrion, Eli Lilly, Innocare, Innovent Biologics, Johnson & Johnson, Novavax, Russian Direct Investment Fund, Sinovac.